Literature DB >> 8207799

Characterization of replication-competent retroviruses from nonhuman primates with virus-induced T-cell lymphomas and observations regarding the mechanism of oncogenesis.

E F Vanin1, M Kaloss, C Broscius, A W Nienhuis.   

Abstract

Rapidly progressive T-cell lymphomas were observed in 3 of 10 rhesus monkeys several months after autologous transplantation of enriched bone marrow stem cells that had been transduced with a retroviral vector preparation containing replication-competent virus (R. E. Donahue, S. W. Kessler, D. Bodice, K. McDonagh, C. Dunbar, S. Goodman, B. Agricola, E. Byrne, M. Raffeld, R. Moen, J. Bacher, K. M. Zsebo, and A. W. Nienhuis, J. Exp. Med. 176:1124-1135, 1992). The animals with lymphoma appeared to be tolerant to retroviral antigens in that their sera lacked antibodies reactive with viral proteins and contained 10(4) to 10(5) infectious virus particles per ml. By molecular cloning and DNA sequencing, we have now demonstrated that the serum from one of the monkeys contained a replication-competent retrovirus that arose by recombination between vector and packaging encoding sequences (vector/helper [V/H] recombinant) in the producer clone used for transduction of bone marrow stem cells. Southern blot analysis demonstrated 14 or 25 copies of this genome per cell where present in two animals. The genome of a second replication-competent virus was also recovered by molecular cloning; it arose by recombination involving the genome of the V/H recombinant and endogenous murine retroviral genomes in the producer clone. Twelve copies of this amphotropic virus/mink cell focus-forming virus genome were present in tumor DNA of one animal, but it was not found in tumor DNA of the other two animals with lymphoma. Southern blot analysis of DNA from various tissues demonstrated common insertion site bands in several samples of tumor DNA from one animal, suggesting clonal origin of the lymphoma. Our data are most consistent with a pathogenic mechanism in which chronic productive retroviral infection allowed insertional mutagenesis of critical growth control genes, leading to cell transformation and clonal tumor evolution.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8207799      PMCID: PMC236347     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  39 in total

1.  Selective extraction of polyoma DNA from infected mouse cell cultures.

Authors:  B Hirt
Journal:  J Mol Biol       Date:  1967-06-14       Impact factor: 5.469

2.  Nucleotide sequence of Moloney murine leukaemia virus.

Authors:  T M Shinnick; R A Lerner; J G Sutcliffe
Journal:  Nature       Date:  1981 Oct 15-21       Impact factor: 49.962

3.  Structure of the baboon endogenous virus genome: cloning of circular virus DNA in bacteriophage lambda.

Authors:  M Noda; M Wagatsuma; T Tamura; T Takano; K Matsubara
Journal:  Nucleic Acids Res       Date:  1981-05-11       Impact factor: 16.971

4.  Nucleotide sequence of AKV murine leukemia virus.

Authors:  W Herr
Journal:  J Virol       Date:  1984-02       Impact factor: 5.103

5.  Envelope gene sequence of two in vitro-generated mink cell focus-forming murine leukemia viruses which contain the entire gp70 sequence of the endogenous nonecotropic parent.

Authors:  G E Mark; U R Rapp
Journal:  J Virol       Date:  1984-02       Impact factor: 5.103

6.  Molecular analysis of the envelope gene and long terminal repeat of Friend mink cell focus-inducing virus: implications for the functions of these sequences.

Authors:  W Koch; W Zimmermann; A Oliff; R Friedrich
Journal:  J Virol       Date:  1984-03       Impact factor: 5.103

7.  Nucleotide sequence of the 3' end of MCF 247 murine leukemia virus.

Authors:  M Kelly; C A Holland; M L Lung; S K Chattopadhyay; D R Lowy; N H Hopkins
Journal:  J Virol       Date:  1983-01       Impact factor: 5.103

8.  Analysis of the env gene of a molecularly cloned and biologically active Moloney mink cell focus-forming proviral DNA.

Authors:  R A Bosselman; F van Straaten; C Van Beveren; I M Verma; M Vogt
Journal:  J Virol       Date:  1982-10       Impact factor: 5.103

9.  Characterization of a highly oncogenic murine leukemia virus from wild mice.

Authors:  S Rasheed; B K Pal; M B Gardner
Journal:  Int J Cancer       Date:  1982-03-15       Impact factor: 7.396

10.  Nucleotide sequence of the gp70 gene of murine retrovirus MCF 247.

Authors:  C A Holland; J Wozney; N Hopkins
Journal:  J Virol       Date:  1983-09       Impact factor: 5.103

View more
  24 in total

1.  DNA methylation of helper virus increases genetic instability of retroviral vector producer cells.

Authors:  W B Young; G L Lindberg; C J Link
Journal:  J Virol       Date:  2000-04       Impact factor: 5.103

2.  Psi- vectors: murine leukemia virus-based self-inactivating and self-activating retroviral vectors.

Authors:  K A Delviks; W S Hu; V K Pathak
Journal:  J Virol       Date:  1997-08       Impact factor: 5.103

3.  A replication-competent retrovirus arising from a split-function packaging cell line was generated by recombination events between the vector, one of the packaging constructs, and endogenous retroviral sequences.

Authors:  H Chong; W Starkey; R G Vile
Journal:  J Virol       Date:  1998-04       Impact factor: 5.103

4.  Self-deleting retrovirus vectors for gene therapy.

Authors:  A P Russ; C Friedel; M Grez; H von Melchner
Journal:  J Virol       Date:  1996-08       Impact factor: 5.103

Review 5.  Pharmaceutical approach to somatic gene therapy.

Authors:  F D Ledley
Journal:  Pharm Res       Date:  1996-11       Impact factor: 4.200

6.  Development of high-titer retroviral producer cell lines by using Cre-mediated recombination.

Authors:  E F Vanin; L Cerruti; N Tran; G Grosveld; J M Cunningham; S M Jane
Journal:  J Virol       Date:  1997-10       Impact factor: 5.103

Review 7.  Gene therapy in pediatric oncology.

Authors:  E Benaim; B P Sorrentino
Journal:  Invest New Drugs       Date:  1996       Impact factor: 3.850

8.  Generation of human induced pluripotent stem cells bearing an anti-HIV transgene by a lentiviral vector carrying an internal murine leukemia virus promoter.

Authors:  Masakazu Kamata; Shirley Liu; Min Liang; Yoshiko Nagaoka; Irvin S Y Chen
Journal:  Hum Gene Ther       Date:  2010-10-06       Impact factor: 5.695

9.  Gene transfer into mammalian cells by a Rous sarcoma virus-based retroviral vector with the host range of the amphotropic murine leukemia virus.

Authors:  E V Barsov; S H Hughes
Journal:  J Virol       Date:  1996-06       Impact factor: 5.103

10.  Live cell monitoring of hiPSC generation and differentiation using differential expression of endogenous microRNAs.

Authors:  Masakazu Kamata; Min Liang; Shirley Liu; Yoshiko Nagaoka; Irvin S Y Chen
Journal:  PLoS One       Date:  2010-07-28       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.